Further, MAIT cells, a T-cell subset that is responsive to gut microbiota-derived riboflavin metabolites and present in GvHD target organs, are shown to suppress activity in GvHD through associated decreases in intestinal barrier integrity and IL-17-mediated Th17 expansion (130). This evidence concerns the gene IL17A and graft versus host disease.